查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573117

犬关节炎市场：按产品类型、给药途径、最终用户、治疗类型 - 全球预测 2025-2030

Canine Arthritis Market by Product Type (Assistive Devices and Joint Support, Disease-Modifying Osteoarthritis Drugs, Non-Steroidal Anti-Inflammatory Drugs ), Route of Administration, End User, Therapy Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

犬关节炎市场2023年估值为18.1亿美元，预计到2024年将达到19.2亿美元，复合年增长率为7.88%，到2030年预计将达到30.8亿美元。

犬关节炎是一种退化性关节疾病，主要影响狗的软骨，导致疼痛、僵硬和运动受损。由于宠物饲养量的增加和老年狗数量的增加等因素，犬关节炎的盛行率不断增加，犬关节炎的治疗和管理市场正在显着扩大。不可否认，狗对有效关节炎治疗的需求是不可否认的，这主要是由于人们对宠物福利的了解有所提高，以及宠物医疗保健人性化的趋势不断增长。关节炎管理的应用范围从药物干预（如非类固醇消炎剂(NSAID) 和缓解疾病骨关节炎药物 (DMOAD)）到非药物干预（如物理治疗、针灸和营养食品）。最终用途包括兽医诊所、宠物医院，甚至是希望维持宠物生活品质的饲主提供的居家照护解决方案。关键的成长要素包括兽医学的进步，提供更新、更有效的治疗方法，以及饲主对关节炎症状和治疗方法的认识提高。同时，在创新、微创治疗技术的开发以及符合消费者对宠物有机和天然健康解决方案的偏好的自然或整体治疗方案的扩散方面存在着开拓的机会。然而，市场成长受到一些挑战的限制，例如与先进治疗相关的高成本、缺乏宠物保险以及新兴市场缺乏意识等。需要创新的领域包括用于早期检测的增强诊断工具和基于个体基因图谱的个人化治疗计划。市场动态的特征是兽药的快速发展和消费者资讯收集的活性化，这意味着公司不仅关注其治疗的有效性，而且还关注扩大消费者教育和可及性，我们需要关注并推动增长。

主要市场统计
基准年[2023] 18.1亿美元
预测年份 [2024] 19.2亿美元
预测年份 [2030] 30.8亿美元
复合年增长率（%） 7.88%

市场动态：揭示快速发展的犬关节炎市场的关键市场洞察

供需的动态交互作用正在改变犬类关节炎市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 由于宠物的老化和生活方式，世界狗群中关节炎的盛行率不断增加
    • 兽医医学和治疗方面的创新可有效控制狗的关节炎
    • 提高饲主对狗的健康和保健的认识和支出意愿
    • 诊断技术的进步导致狗关节炎的早期发现和治疗
  • 市场限制因素
    • 专业兽医数量不足，无法妥善处理犬类关节炎病例
    • 影响犬关节炎新治疗方法的核准和可用性的监管挑战
  • 市场机会
    • 犬关节炎专科治疗中心提供全面全面的医疗方法
    • 为患有关节炎的狗订购关节补充品和止痛药
    • 用于持续监测和管理狗的关节炎症状的可穿戴技术
  • 市场挑战
    • 兽医护理和关节炎治疗的高昂成本减少了市场进入。
    • 缺乏饲主对狗关节炎早期症状和预防保健的认识和教育

波特的五力：驾驭犬关节炎市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解犬关节炎市场的外部影响

外部宏观环境因素在塑造犬关节炎市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解狗狗关节炎市场的竞争格局

犬关节炎市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵犬关节炎市场供应商的绩效评估

FPNV 定位矩阵是评估犬关节炎市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了犬关节炎市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对犬关节炎市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 宠物的老化和生活方式的改变正在增加世界各地狗狗关节炎的盛行率
      • 兽医药物和治疗方法的创新可有效控制狗的关节炎
      • 提高狗狗的健康意识和饲主花钱的意愿
      • 诊断技术的进步导致狗关节炎的早期发现和治疗
    • 抑制因素
      • 没有足够的专业兽医专业人员来充分处理狗的关节炎病例。
      • 影响犬关节炎新治疗方法的核准和可用性的监管挑战
    • 机会
      • 专业犬类关节炎治疗中心提供全面且整体的医疗方法
      • 为患有关节炎的狗定期提供关节补充品和止痛药
      • 穿戴式科技持续监测和管理狗狗的关节炎症状
    • 任务
      • 兽医和关节炎治疗的高昂成本限制了市场进入
      • 宠物饲主对狗关节炎的早期征兆和预防保健缺乏认识和教育。
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章犬关节炎市场：依产品类型

  • 辅助器具和关节支持
    • 大括号
    • 线束
    • 其他辅助器具
  • 骨关节炎治疗药（DMOAD）
    • 结构修饰DMOAD
    • 症状性DMOAD
  • 非类固醇消炎剂(NSAID)
    • 市售非类固醇抗发炎药
    • 处方非类固醇抗发炎药
  • 疼痛管理药物
    • 阿片类药物
    • 其他止痛药
    • 类固醇
  • 手术治疗
    • 关节镜手术
    • 关节重建手术
    • 其他手术治疗

第七章犬关节炎市场：依给药途径

  • 可注射的
  • 口服
  • 话题

第八章犬关节炎市场：依最终用户分类

  • 网路药房
  • 零售药房
  • 兽医医院和诊所

第 9 章依治疗类型分類的犬关节炎市场

  • 药物治疗
  • 物理治疗
    • 针刺
    • 水疗
    • 雷射治疗
    • 其他物理治疗
  • 手术治疗

第10章美洲犬关节炎市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太犬关节炎市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的犬关节炎市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C0106

The Canine Arthritis Market was valued at USD 1.81 billion in 2023, expected to reach USD 1.92 billion in 2024, and is projected to grow at a CAGR of 7.88%, to USD 3.08 billion by 2030.

Canine arthritis, a degenerative joint disease, primarily affects the cartilage in dogs, leading to pain, stiffness, and impaired movement. As the prevalence of arthritis in dogs rises, driven by factors such as increasing pet ownership and a growing population of aged dogs, the market for canine arthritis treatment and management is expanding significantly. The necessity for effective arthritis treatments in dogs is undeniable, primarily due to the enhanced understanding of pet welfare and the increasing trend towards humanizing pet healthcare. Applications for arthritis management range from pharmaceutical interventions, such as non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying osteoarthritis drugs (DMOADs), to non-pharmaceutical therapies like physiotherapy, acupuncture, and dietary supplements. The end-use scope involves veterinary clinics, pet hospitals, and even in-home care solutions provided by pet owners who wish to maintain their pets' quality of life. Key growth influencers are advancements in veterinary medicine that provide newer, more effective treatments, and heightened awareness among pet owners about arthritis symptoms and treatment options. Meanwhile, untapped opportunities reside in the development of innovative, minimally invasive treatment techniques and the proliferation of natural or holistic treatment options, aligning with consumer preferences for organic and natural health solutions for their pets. Nonetheless, the market's growth is curtailed by challenges such as high costs associated with advanced treatments, lack of insurance coverage for pets, and insufficient awareness in developing regions. Areas ripe for innovation include enhanced diagnostic tools for early detection and personalized treatment plans based on individual genetic profiles. The nature of the canine arthritis market is dynamic, characterized by rapid advancements in veterinary science and an increasingly informed consumer base, suggesting that businesses should focus not just on treatment efficacy but also on educating consumers and broadening accessibility to drive growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.81 billion
Estimated Year [2024] USD 1.92 billion
Forecast Year [2030] USD 3.08 billion
CAGR (%) 7.88%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Canine Arthritis Market

The Canine Arthritis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of arthritis among the global canine population due to aging pets and lifestyle
    • Innovations in veterinary medicine and treatments for managing canine arthritis effectively
    • Growing awareness and pet owner's willingness to spend on canine health and wellness
    • Advancements in diagnostic techniques leading to early detection and treatment of arthritis in dogs
  • Market Restraints
    • Insufficient number of specialized veterinary professionals to adequately address canine arthritis cases
    • Regulatory challenges affecting the approval and availability of novel treatments for canine arthritis
  • Market Opportunities
    • Specialized canine arthritis treatment centers offering holistic and integrative medical approaches
    • Subscription-based delivery of joint supplements and pain relief medications for arthritic dogs
    • Wearable technology for continuous monitoring and management of arthritis symptoms in dogs
  • Market Challenges
    • High costs associated with veterinary care and arthritis treatments leading to reduced market accessibility
    • Lack of awareness and education among pet owners about early signs and preventive care for canine arthritis

Porter's Five Forces: A Strategic Tool for Navigating the Canine Arthritis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Canine Arthritis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Canine Arthritis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Canine Arthritis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Canine Arthritis Market

A detailed market share analysis in the Canine Arthritis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Canine Arthritis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Canine Arthritis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Canine Arthritis Market

A strategic analysis of the Canine Arthritis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Canine Arthritis Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Merck Animal Health, Nutramax Laboratories, Inc., Vetoquinol S.A., Virbac, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Canine Arthritis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Assistive Devices and Joint Support, Disease-Modifying Osteoarthritis Drugs (DMOADs), Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Management Drugs, and Surgical Treatments. The Assistive Devices and Joint Support is further studied across Braces, Harnesses, and Other Assistive Devices. The Disease-Modifying Osteoarthritis Drugs (DMOADs) is further studied across Structure-Modifying DMOADs and Symptomatic DMOADs. The Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is further studied across Over-the-Counter NSAIDs and Prescription NSAIDs. The Pain Management Drugs is further studied across Opioids, Other Pain Management Drugs, and Steroids. The Surgical Treatments is further studied across Arthroscopic Surgery, Joint Replacement Surgery, and Other Surgical Treatments.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on End User, market is studied across Online Pharmacies, Retail Pharmacies, and Veterinary Hospitals and Clinics.
  • Based on Therapy Type, market is studied across Drug Therapy, Physical Therapy, and Surgical Therapy. The Physical Therapy is further studied across Acupuncture, Hydrotherapy, Laser Therapy, and Other Physical Therapies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of arthritis among the global canine population due to aging pets and lifestyle
      • 5.1.1.2. Innovations in veterinary medicine and treatments for managing canine arthritis effectively
      • 5.1.1.3. Growing awareness and pet owner's willingness to spend on canine health and wellness
      • 5.1.1.4. Advancements in diagnostic techniques leading to early detection and treatment of arthritis in dogs
    • 5.1.2. Restraints
      • 5.1.2.1. Insufficient number of specialized veterinary professionals to adequately address canine arthritis cases
      • 5.1.2.2. Regulatory challenges affecting the approval and availability of novel treatments for canine arthritis
    • 5.1.3. Opportunities
      • 5.1.3.1. Specialized canine arthritis treatment centers offering holistic and integrative medical approaches
      • 5.1.3.2. Subscription-based delivery of joint supplements and pain relief medications for arthritic dogs
      • 5.1.3.3. Wearable technology for continuous monitoring and management of arthritis symptoms in dogs
    • 5.1.4. Challenges
      • 5.1.4.1. High costs associated with veterinary care and arthritis treatments leading to reduced market accessibility
      • 5.1.4.2. Lack of awareness and education among pet owners about early signs and preventive care for canine arthritis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Canine Arthritis Market, by Product Type

  • 6.1. Introduction
  • 6.2. Assistive Devices and Joint Support
    • 6.2.1. Braces
    • 6.2.2. Harnesses
    • 6.2.3. Other Assistive Devices
  • 6.3. Disease-Modifying Osteoarthritis Drugs (DMOADs)
    • 6.3.1. Structure-Modifying DMOADs
    • 6.3.2. Symptomatic DMOADs
  • 6.4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • 6.4.1. Over-the-Counter NSAIDs
    • 6.4.2. Prescription NSAIDs
  • 6.5. Pain Management Drugs
    • 6.5.1. Opioids
    • 6.5.2. Other Pain Management Drugs
    • 6.5.3. Steroids
  • 6.6. Surgical Treatments
    • 6.6.1. Arthroscopic Surgery
    • 6.6.2. Joint Replacement Surgery
    • 6.6.3. Other Surgical Treatments

7. Canine Arthritis Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Canine Arthritis Market, by End User

  • 8.1. Introduction
  • 8.2. Online Pharmacies
  • 8.3. Retail Pharmacies
  • 8.4. Veterinary Hospitals and Clinics

9. Canine Arthritis Market, by Therapy Type

  • 9.1. Introduction
  • 9.2. Drug Therapy
  • 9.3. Physical Therapy
    • 9.3.1. Acupuncture
    • 9.3.2. Hydrotherapy
    • 9.3.3. Laser Therapy
    • 9.3.4. Other Physical Therapies
  • 9.4. Surgical Therapy

10. Americas Canine Arthritis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Canine Arthritis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Canine Arthritis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bayer AG
  • 2. Boehringer Ingelheim International GmbH
  • 3. Ceva Sante Animale
  • 4. Dechra Pharmaceuticals PLC
  • 5. Elanco Animal Health Incorporated
  • 6. Merck Animal Health
  • 7. Nutramax Laboratories, Inc.
  • 8. Vetoquinol S.A.
  • 9. Virbac
  • 10. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. CANINE ARTHRITIS MARKET RESEARCH PROCESS
  • FIGURE 2. CANINE ARTHRITIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CANINE ARTHRITIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CANINE ARTHRITIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CANINE ARTHRITIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CANINE ARTHRITIS MARKET DYNAMICS
  • TABLE 7. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY BRACES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HARNESSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OTHER ASSISTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY STRUCTURE-MODIFYING DMOADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SYMPTOMATIC DMOADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OVER-THE-COUNTER NSAIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PRESCRIPTION NSAIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OTHER PAIN MANAGEMENT DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY STEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ARTHROSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY JOINT REPLACEMENT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OTHER SURGICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYDROTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OTHER PHYSICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 82. CANADA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 83. CANADA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 134. CHINA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 135. CHINA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 144. INDIA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 145. INDIA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 147. INDIA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 156. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 157. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 166. JAPAN CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 167. JAPAN CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. JAPAN CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. JAPAN CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 186. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 196. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 197. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 216. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 217. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. THAILAND CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. THAILAND CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. THAILAND CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. THAILAND CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. THAILAND CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 236. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 237. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 238. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 257. DENMARK CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 258. DENMARK CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 259. DENMARK CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. DENMARK CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. DENMARK CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 267. EGYPT CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 268. EGYPT CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 269. EGYPT CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. EGYPT CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. EGYPT CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 277. FINLAND CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 278. FINLAND CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. FINLAND CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. FINLAND CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. FINLAND CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 287. FRANCE CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 288. FRANCE CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 289. FRANCE CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 290. FRANCE CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. FRANCE CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 297. GERMANY CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 298. GERMANY CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 299. GERMANY CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 300. GERMANY CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. GERMANY CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 307. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 308. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 309. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 315. ITALY CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 316. ITALY CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 317. ITALY CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 318. ITALY CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 319. ITALY CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 320. ITALY CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)